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Abstract 
Rationale. Previous findings report use of the drug ecstasy (MDMA) to be 
associated with lower emotional intelligence (EI), and compromised functioning in 
brain areas responsible for emotion. This study explored the relationship between 
ecstasy use, EI, mood, and parenting styles. Design. Questionnaire measures of drug 
use, lifestyle, parenting style, and EI were obtained, with separate IQ measures for 
fluid intelligence (Ravens matrices) and pre-morbid intelligence (NART). Current 
mood measures were obtained from an adjective checklist. Method. The sample 
comprised 78 ecstasy/polydrug users, 38 cannabis only users, and 34 non-drug users. 
Drug use was categorised at three levels (non-user, cannabis-only user, and ecstasy 
polydrug user). Results.  Factorial ANOVA using drug use as an independent variable 
showed no significant group effects in EI. EI showed significant correlations with 
current mood which were positive for arousal, and negative for both anxiety and 
depression. EI was also significantly and positively correlated with the perceived 
degree of parental control. Regression analyses revealed that these relationships 
remained significant with IQ, age, gender, and ecstasy use controlled. Adverse mood 
effects specifically associated with ecstasy use were significantly related to lower EI, 
and were independent of IQ, age and gender. Higher EI was significantly associated 
with ecstasy related precautions used when taking this drug.  Conclusions. Contrary to 
earlier findings, ecstasy polydrug users did not differ from non-users on EI. However, 
self-reported ecstasy related mood disturbances were related to lower EI, with the 
compromising of orbitofrontal cortical functioning being possible here. 
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3,4-Methylenedioxymethamphetamine (MDMA; 'Ecstasy') is a 
psychostimulant drug producing heightened mood and facilitated social 
communication.  Animal studies have demonstrated the neurotoxic effects of ecstasy 
on serotonergic transmitters (Battaglia et al 1987; Hatzidimitriou et al, 1999); 
however research of this kind is not so readily available for human participants. Those 
studies that do exist suggest that MDMA exposure in humans can cause decreased 
tissue stores of serotonin and therefore some of the behavioural effects could be 
caused by a massive release and subsequent depletion of brain serotonin (Kish et al, 
2000).  Functional depletion can remain for a long time after use, with abstinent users 
showing a lower density of 5-HT transporters (Parrott, 2002) causing problems such 
as a loss of appetite and sexual interest (Parrott et al 2001).  Studies from our own 
laboratory reveal that ecstasy users perform worse on measures of executive 
functioning, associative learning, and reasoning compared to non-user controls (Fisk 
et al, 2005; Montgomery et al, 2005a; 2005b).  Other researchers have also found 
evidence of ecstasy-related deficits in various aspects of cognition, for example in 
learning and memory performance (e.g., Gouzoulis-Mayfrank et al 2000), working 
memory and executive functioning (e.g., Fox et al 2001; 2002) and everyday memory 
(e.g., Heffernan et al 2001).  
With regard to social and emotional functioning, using low resolution 
electromagnetic tomography, Frei et al (2001) found that administration of 1.7mg/kg 
of MDMA
1
 to human volunteers gave rise to a widespread decrease of slow and 
medium frequency activity and an increase of fast frequency activity in the anterior 
temporal and posterior orbital cortex. Volunteers also completed a mood adjective 
rating scale. MDMA administration significantly boosted the scores associated with 
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extraversion, well-being (heightened mood and self confidence), emotional 
excitability and anxiety. The activation of frontotemporal areas suggests that the 
observed enhancement of mood and the increased extroversion are a consequence of 
the action of MDMA on the limbic orbitofrontal and anterotemporal structures known 
to be involved in emotional processing (Frei et al 2001).  
Given these substantial effects of MDMA on emotional processing, it may be 
the case that emotional intelligence (EI) is affected by ecstasy use.  Over time the 
potentially neurotoxic effects of ecstasy use might impair aspects of emotional 
expression and appraisal. From an alternative perspective individuals who have pre-
existing low EI might be more likely to use ecstasy. EI scores have been found to be 
negatively correlated with measures of alcohol and tobacco use (Trinidad & Johnson, 
2002). Furthermore, using multiple regression and logistic regression, Trinidad et al 
(2004) found that higher EI scores were associated with more negative perceptions 
concerning smoking and with a reduced intention to smoke over the coming year.  
With regard to illicit substances, individuals in a substance abuse treatment 
programme were found to have significantly lower levels of EI compared to a control 
group (Schutte et al, 1998). Furthermore, EI has been found to be negatively 
correlated with reported drug and alcohol-related problems. Regression analysis 
revealed that EI accounted for 13% of the variance in reported alcohol-related 
problems and 17% of the variance in reported drug-related problems. Those scoring 
higher on the EI measure reported fewer problems (Riley & Schutte, 2003). 
An important, if not the only determinant of EI is thought to be parenting 
practices. Utilizing path analysis Martinez-Pons (1998) found that indicators of 
parental modelling, facilitation, and encouragement were positively associated with 
children’s EI scores. Furthermore EI scores were positively related to measures of 
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social functioning. Correlational analysis revealed that the managing emotions 
component of EI was positively and significantly associated with the degree of 
perceived parental support (Lopes et al, 2003). In subsequent analyses, statistical 
regression revealed that this association remained significant following controls for 
individual differences in personality and verbal intelligence (Lopes et al, 2003). In 
more recent research, secure attachment relationships with both parents and peers 
have been found to be significantly related to aspects of adolescent emotional 
expressiveness, emotional awareness and social competence (Laible, 2007). Similar 
findings linking aspects of attachment relationships and EI have been reported by 
Scharfe (2000), Hall et al (2004), Kim (2005), and Kafetsios (2004). In all these 
studies secure attachment patterns are positively associated with EI.  
Interestingly, research with substance misusers has found that they 
retrospectively rate their parents as more rejecting, more restrictive, and lower on 
warmth than do non-drug using controls (Emmelkemp & Heeres, 1988; Schweitzer & 
Lawton, 1989). In a recent study from our laboratory we found that ecstasy-polydrug 
users were more likely to rate their parents’ style as neglectful (lacking in control and 
warmth) compared to nonusers (Montgomery et al, in press). Assuming that their 
subjective perceptions are accurate, this raises the possibility that ecstasy users might 
exhibit deficits in EI as a consequence of impaired parenting practices and not as a 
direct result of ecstasy use. 
It is important to understand the basis of individual differences in EI since 
these appear to have implications for mood and well being. A number of studies from 
different countries with college and high school students have demonstrated that 
higher scores on the EI measure are associated with lower levels of anxiety and 
depression. For example, Wang (2002) found that EI scores were negatively 
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correlated with outcomes on anxiety and depression measures. Utilizing hierarchical 
regression, Fernández-Berrocal et al (2006) found that the EI measure uniquely 
accounted for 11% of the variance in depression scores (as measured by the BDI) and 
22% of the variance in anxiety (as measures by the STAI).  Bastian et al (2005) also 
reported an association between EI scores on the one hand and anxiety and life 
satisfaction on the other. However in this case EI uniquely accounted for no more 
than 7% of the variance in question. It is possible therefore, that differences in EI 
between ecstasy users and nonusers might be a factor in accounting for ecstasy-related 
problems in psychological health. For example, ecstasy-polydrug users have been 
found to exhibit negative psychological affect. In an internet based study in which 
almost 300 ecstasy users took part, the level of ecstasy use was found to be 
significantly associated with depression, anxiety and mood fluctuations (Parrott et al 
2002). While effect sizes are not reported in this study, 65% of heavy users reported 
depression as a consequence of ecstasy use compared with 33% of novice users. The 
equivalent figures for anxiety were 60% for heavy users and 32% for novice. 
Similarly, in a large scale European based study, ecstasy use was significantly 
associated with phobic anxiety, and non-specific anxiety, and a range of other adverse 
psychiatric symptoms in a dose related manner (Parrott et al 2001), although again it 
must be conceded that effect sizes were not reported. 
Thus it is possible that individual differences in EI may be associated with 
ecstasy use due to the psychopharmacological action of MDMA on the orbito-frontal 
cortex. Alternatively the association may be as a result of pre-existing differences 
between users and nonusers (e.g., in aspects of perceived parenting style) which 
adversely affect EI and increase the likelihood of substance use perhaps as a form of 
self medication. In either case the adverse effects on mood associated with ecstasy use 
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might be entirely mediated by individual differences in EI. Despite the possible links 
between ecstasy use and EI there has been relatively little research addressing these 
issues. In an important recent study, Reay, et al (2006) investigated a group of 
polydrug ecstasy users and polydrug non-ecstasy users on a variety of central 
executive tasks and background measures.  The aim of the research was to assess the 
potential impact of MDMA use specifically on the social and emotional judgement 
processes mediated by the prefrontal cortex.  Ecstasy-polydrug users achieved 
significantly lower scores on an EI questionnaire, and the ecstasy-related deficit 
remained apparent even after controlling for the use of other drugs.  Reay et al argue 
that social and emotional processing may be substantially impaired as a consequence 
of the consumption of illicit substances, in particular ecstasy. However, some 
limitations of this study need to be attended to, in particular the small sample size of 
the experimental group and the disparity in the level of cannabis consumption 
between the experimental and control groups. While cannabis use was apparently not 
directly associated with EI it is possible that the two drugs (ecstasy and cannabis) 
might have interacted to produce an effect in the experimental group.  
The present study differs from that of Reay et al in that a substantially larger 
sample will be tested including ecstasy-polydrug users, cannabis-only users and 
nonusers of illicit drugs.  Indices quantifying ecstasy and other drug use will be 
collected, and in addition to assessing the role of EI, a perceived rating of parenting 
style will be included in order to explore how this may mediate the relationship 
between EI and drug use. We also intend to explore whether or not differences in 
psychological affect among drug users and nonusers are related to EI. Aside from the 
possibility of differences between users and nonusers, we also plan to explore whether 
differences in EI within the ecstasy-using group are associated with differences in 
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perceptions regarding how the drug has changed their mood, emotional expression 
and drug related behaviours.  
It was predicted that ecstasy-polydrug users would score lower on the measure 
of EI, with non users scoring the highest.  Furthermore the possibility that parenting 
practices might mediate differences in EI between drug users and nonusers resulting 
in group differences in psychological affect was to be explored. 
Method 
Design 
The independent variable (IV) was drug use (non-user, cannabis only user and 
polydrug user). The dependent variable (DV) was EI. The basis of any drug-related 
differences in EI will be explored though analysis of covariance with the parenting 
measures (control and warmth), and measures of general intelligence as covariates. 
Drug related differences in the measures of psychological affect will also be explored 
with drug use (as defined above) as the IV and the measures of psychological affect 
(anxiety, arousal, depression/hedonic tone) as DVs. The source of any drug-related 
differences in the psychological affect measures will be further explored using 
ANCOVA with the EI and the parenting measures as covariates. 
In order to corroborate the research findings set out in the introduction linking 
EI with psychological affect and EI with aspects of substance use, additional analyses 
were also conducted: first we examined the relationship between EI and respectively 
parental warmth, control, the psychological affect measures and the other measures of 
general intelligence using correlational analysis. It was expected that EI would be 
negatively correlated with parental warmth and control and with the psychological 
affect measures. Where correlations were statistically significant the relationship 
between EI and these other variables was further explored through hierarchical 
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regression analysis. Second, the relationship between users’ perceptions of how 
ecstasy had affected their feelings and their EI scores was explored through 
correlational analysis. It was predicted that increases in negative feelings attributed to 
ecstasy use would be inversely associated with EI. Where correlations were 
statistically significant the relationship between EI and perceptions of ecstasy use was 
further explored through hierarchical regression analysis. Third we explored whether 
those who engage in a particular protective behaviour (e.g., monitoring fluid intake) 
differ in terms of EI from those who do not. The presence or absence of the behaviour 
was the IV, with EI as the DV. 
Participants 
Participants were recruited via direct approach to university students, and the 
snowball technique.  Participants were requested to refrain from ecstasy use for at 
least 7 days prior to testing and were also requested not to use any other illicit drug 
for at least 24 hours prior to testing.  Ecstasy users have been shown to experience a 
depressed mood state in the 3 to 4 days following last use (Curran & Travill, 1997) 
and therefore the 7 day abstinence period was deemed appropriate.  
Data were available for 161 participants. Of these 34 (28 female) were non-
users of illicit substances, 38 (27 female) used cannabis only, and 78 (35 female) were 
polydrug users all of whom had consumed two or more illicit drugs one of which was 
ecstasy.  Background data including age, general intelligence, indicators of alcohol 
and tobacco use are reported in Table 1. Indicators of illicit drug use for the two drug 
using groups are set out in Table 2. It is worthy of note that cannabis was also popular 
amongst ecstasy/polydrug users who reported higher levels of use than the cannabis-
only group. 
<<Insert Tables 1 and 2 here>> 
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Materials  
Patterns of drug use and other relevant lifestyle variables were investigated via 
means of a background questionnaire. Ecstasy users were asked if they believed that 
since using ecstasy they had changed in any way. They responded to each of the 
following words: caring, paranoid, alert, depressed, sociable, aggressive, happy, 
healthy, moody, patient, irritable, confident, sad, loving, and confused, using a five 
point scale: much more 5, more 4, no change 3, less 2, and much less 1 (see Murphy 
et al 2006). Ecstasy users also responded ‘Yes’ or ‘No’ to the following questions: 
‘Do you take any sort of precautions when using ecstasy?’, ‘When under the influence 
of ecstasy do you take rest breaks when dancing?’, ‘When under the influence of 
ecstasy do you monitor your fluid intake?’, and ‘Is there a maximum number of 
ecstasy tablets you will take in one session?’ 
In relation to drug use, participants were asked a range of questions including 
duration of use, and the last time that they had used each drug. Participants were also 
questioned concerning their history of drug use, and these data were used to estimate 
total lifetime use for each drug. Average weekly dose for each drug was also assessed.  
Parental Warmth and Control: To assess both of these dimensions, we used the 
acceptance/involvement and strictness/supervision scales of the Parenting Style 
Questionnaire (Lamborn et al 1991). The acceptance/involvement scale measures the 
extent to which a participant perceives their parents as loving, responsive and 
involved (e.g. “I can count on them to help me out when I have a problem”; “When 
they want me to do something, they explain why”). This subscale contains 10 items.  
The strictness/supervision scale assesses parental monitoring and control of the 
participant (e.g. “How much do your parents try to know where you are at night?”  
“How late were you allowed to stay out on a school night?”). This subscale contains 9 
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items. Participants were asked to reflect back to their teenage years, when they were 
living at home and in full time education. Thus their judgements were retrospective in 
nature. 
For both scales, some of the items were in a true/false format, while others 
were on a Likert scale (ranging from three to 10 points). Following the procedure 
adopted by Lamborn et al (1991), the items were weighted to adjust for differences in 
scaling, and then the scores for the items in each dimension were summed to form 
composite indices for warmth and control (with high scores being indicative of high 
warmth/control). The validity and reliability of the scales have been documented in 
previous research (Alvarez et al, 2003; Lamborn et al, 1991; Slicker et al 2004). 
Emotional Intelligence. EI was measured by the questionnaire developed by 
Schutte et al (1998) which in turn was based on the model developed by Salovey and 
Mayer (1990).  This measure is shown to have good internal consistency (Cronbach 
alpha = 0.87) and test-retest reliability (r=.78) (Schutte et al, 1998). Predictive and 
discriminant validity (Schutte et al, 1998) and construct validity in general have been 
thoroughly investigated in subsequent research (e.g., Schutte et al 2002). The measure 
contains 33 items, three of which are reverse scored. For each item the participant 
responds on a five point scale, 1 strongly disagree, 2 somewhat disagree, 3 neither 
agree nor disagree, 4 somewhat agree, 5 strongly agree. Items include, for example, ‘I  
am aware of my emotions as I experience them’ and ‘I like to share my emotions with 
others’.  A high score is indicative of high EI. 
General Intelligence. Fluid intelligence was measured via Raven’s Progressive 
Matrices (Raven et al, 1998), and premorbid intelligence was assessed via the 
National Adult Reading Test (NART, Nelson, 1982).  These measures were included 
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as controls to ensure that any correlations between EI and the other variables of 
interest were not mediated by individual differences in general intelligence. 
Mood adjective checklist: Anxiety, depression/hedonic tone, and arousal were 
measured by means of a mood adjective checklist (see Matthews et al, 1990; Wareing 
et al, 2000). Of the 18 words on the checklist, six words mapped onto each of these 
three constructs. For each word participants rated themselves as either: not at all, 
slightly, moderately, very, or extremely. The items covering anxiety were: tense, 
calm*, contented*, uneasy, worried, relaxed*; those covering arousal were: fatigued*, 
alert, full of energy, lifeless*, lively, tired*; those covering depression/hedonic tone 
were: enthusiastic*, sad, gloomy, depressed, happy*, cheerful*. Asterisked items 
were reverse scored. Maximum and minimum scores on the measures range from 6 to 
30 with a midpoint of 18, and a total score for each measure was calculated by 
summing the responses (taking into account the reverse scoring). High scores are 
indicative of higher levels of perceived arousal, anxiety, and depression. 
Procedure 
Participants were informed of the general purpose of the experiment, and 
written informed consent was obtained. The tests were administered under laboratory 
conditions in the following order: mood adjective checklist, background drug use 
questionnaire, Ravens progressive Matrices, NART, and EI. Participants performed 
various other pencil and paper and computer based tasks, the results of which have 
been reported elsewhere (e.g., Montgomery et al 2005a; in press). Participants were 
fully debriefed, paid £15 in store vouchers, and given drugs education leaflets. The 
study was approved by the Ethics Committee of Liverpool John Moore’s University, 
and was administered in accordance with the ethical guidelines of the British 
Psychological Society.  
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Results 
 
Inspection of Table 1 reveals that contrary to prediction, there were no 
substantial group differences in EI. Consistent with this,  between-participants 
ANOVA with EI as the dependent variable and the drug groups as independent 
variables yielded F(2,147) = .020, p >.05.  Thus there were no statistically significant 
group differences in EI. Also apparent in the results set out in Table 1, ecstasy-
polydrug users reported lower levels of parental warmth and control compared to the 
other two groups. The group related differences in parenting style have been analysed 
and reported elsewhere (Montgomery et al, in press). The purpose of including these 
measures of parental warmth and control in the present study had been to establish the 
extent to which they mediated group differences in EI. However, since no group 
differences in EI were found this was not possible.  
While we had expected that the groups would differ in terms of the 
psychological affect measures, none of the drug-related differences in anxiety, arousal 
and depression/hedonic tone were statistically significant, F<1.37 in all cases.  In 
view of the absence of group differences on these measures, the planned ANCOVAs 
were not conducted. 
Focussing on the ecstasy-polydrug group, inspection of Table 3 reveals that 
there was a statistically significant negative correlation between the EI scores and 
scores in relation to paranoia, depression, and sadness. Specifically those users who 
said that ecstasy had made them more paranoid, depressed or sad tended to score 
lower on the EI measure. Similarly EI was found to be positively correlated with 
patience. The correlations with scores on the other items were non-significant. Further 
examination of these statistically significant correlations revealed that the modal 
response was ‘no change’. Thus more users indicated that ecstasy had resulted in no 
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change in paranoia (n=29), depression (n=39), patience (n=47), and sadness (n=52). 
However in each case a substantial minority indicated that ecstasy had made them 
more paranoid (n=27), more depressed (n=21), less patient (n=13), and more sad 
(n=8). In all cases those who experienced adverse effects of ecstasy had lower mean 
EI scores, with the EI scores significantly lower in the case of depressed t (58) = 3.50, 
p<.001; and sadness t (58) = 2.84, p<.01.  
<<Insert Table 3 here>> 
The significant correlations between the users’ perceptions of how ecstasy had 
changed them (in relation to paranoia, depression, patience and sadness) and the EI 
measure were noteworthy. However, it is possible that other variables such as general 
intelligence, age, gender, length of ecstasy use and lifetime dose may be related to 
users’  perceptions and that the relationship with EI may not be statistically significant 
when the effects of these other possibly confounding variables are taken into 
consideration. To address this possibility a number of hierarchical regressions were 
conducted. The dependent variable was the user’s perception of how ecstasy had 
changed them (separate regressions were run for paranoia, depression, patience and 
sadness). In the first step of the hierarchy, gender, age and the two measures of 
intelligence (Ravens progressive matrices and the NART) were entered as 
independent variables; in the second step, total ecstasy use and the length of ecstasy 
use were entered. In the final step the EI measure was entered. For each step the 
increment in the R squared value was evaluated and the regression coefficients for the 
full model were considered. The results are set out in Table 4. In relation to the 
paranoid, depressed and sad perceptions, EI was a statistically significant predictor in 
the full model and was associated with a statistically significant increment in the R 
squared value following control for all other variables. Of the other predictors only 
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the Ravens (in the regressions of the paranoid and patient change perceptions) and 
NART (in the regression of the patient change perceptions) measures were 
statistically significant in the full model. 
<<Insert Table 4 here>> 
We also classified users according to whether or not they indicated that they 
took precautions or rest breaks when using ecstasy and whether or not they monitored 
their fluid intake or restricted the number of tablets taken is a single session. The 
results set out in Table 5 revealed that those users who indicated that they took regular 
rest breaks when dancing or who indicated that they monitored their fluid intake 
scored significantly higher on EI than those who did not. Furthermore this difference 
remained statistically significant following control for differences in the Raven’s and 
NART measures. 
<<Insert Table 5 here>> 
Within the ecstasy-polydrug using group, it appears that the significant 
relationship between the perceptions associated with ecstasy use and EI is 
independent of the outcomes on the other measures of intelligence. Thus individual 
differences in EI reflect personal characteristics which appear to be unrelated to 
traditional measures of intelligence. Consistent with this proposition, and focussing on 
the whole sample, inspection of Table 3 reveals that the EI measure was not 
significantly correlated with either of the other two IQ measures.  Since ecstasy-
polydrug, cannabis only, and nonusers did not differ on the EI measure it appears that 
this variable does not mediate group differences in psychological affect. In fact 
inspection of Table 1 reveals that the three groups scored similarly in terms of 
anxiety, arousal and depression/hedonic tone. However, it is clear from Table 3 that 
EI was significantly correlated with all three measures of psychological affect. People 
 16 
with higher EI reported higher levels of arousal, and lower levels of anxiety and 
depression.  Inspection of Table 3 also reveals that parental control (but not parental 
warmth) was significantly correlated with EI. Those participants who perceived their 
parents as exhibiting more control tended to score higher on the EI measure. 
As was the case for the significant correlations between EI and the perceptions 
of the effects of ecstasy use, a number of hierarchical regressions were conducted 
exploring the relationship between EI and respectively the psychological affect 
measures and parental control. Separate regressions were run with anxiety, arousal, 
depression/hedonic tone and parental control respectively as dependent variables. In 
the first step of the hierarchy, gender, age and the two measures of intelligence 
(Ravens progressive matrices and the NART) were entered as independent variables; 
in the second step, ecstasy use was entered with users coded as 0 and nonusers as 1. In 
the final step the EI measure was entered. For each step the increment in the R 
squared value was evaluated and the regression coefficients for the full model were 
considered. The results are set out in Table 6. In all of the analyses, EI was a 
statistically significant predictor in the full model and was associated with a 
statistically significant increment in the R squared value following control for all 
other variables. Of the other predictors only gender was statistically significant in the 
full model (in the regression of parental control). 
<<Insert Table 6 here>> 
Discussion 
Contrary to prediction we found no significant differences in EI between 
ecstasy/polydrug users, cannabis-only users and non-users.  Our findings may be 
contrasted with those of Reay et al (2006) who found that ecstasy users scored lower 
than drug using controls on this particular measure.  Reay et al’s sample (N = 30) was 
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considerable smaller than ours (N=150) and may have differed in terms of lifetime 
exposure or frequency of use of ecstasy.  For example Reay et al’s users consumed an 
average of 11.1 tablets per month for an average of 4.3 years yielding an estimated 
lifetime dose of 593 tablets compared with the mean for our sample which was 316 
tablets. Thus it is possible that EI deficits emerge as a consequence of greater lifetime 
exposure to ecstasy.  Furthermore, the average age of Reay et al’s ecstasy users was 
older compared with our ecstasy/polydrug group and they appear to have used ecstasy 
for marginally longer. It is also worthy of note that the mean period of abstinence for 
our sample was almost 30 weeks (although the median was appreciably less at 3.5 
weeks) and since equivalent figures are not available for Reay et al’s sample the two 
may have differed in this respect also. It is also worthy of note that a large proportion 
of our ecstasy/polydrug group used cocaine in addition to the other drugs, while as far 
as can be established cocaine use was relatively rare among Reay et al’s group. Thus 
it is possible that the characteristics of the population from which our polydrug group 
was drawn differed in other potentially important respects from that of Reay et al’s.   
However, alongside the overall trend, a minority of our ecstasy/polydrug users 
did produce significantly lower EI scores compared to the majority of users. These 
were individuals who reported negative side effects associated with ecstasy use. Thus 
a further possibility is that Reay et al’s sample inadvertently included a 
disproportionate number of individuals with negative perceptions regarding ecstasy 
use. In our sample, these negative perceptions all involve aspects of emotional 
processing (depression, sadness, patience and paranoia) which are known to involve 
the orbitofrontal cortex (Davidson et al 2000). Furthermore, this region of the brain is 
known to be acutely affected by ecstasy use (Frei et al, 2001). Among our participants 
these negative perceptions were attributed to ecstasy use, suggesting that they had 
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arisen after the onset of use and did not directly reflect some pre-existing condition. 
This raises the possibility that a subset of users may experience negative emotional 
reactions as a possible consequence of MDMA neurotoxicity and that these 
individuals are also more likely to manifest impaired EI. It remains unclear why all 
ecstasy users are not affected in this way.  
An additional finding from the present study was that ecstasy users who failed 
to take protective measures (e.g., taking rest breaks and monitoring fluid intake) while 
on drug had significantly lower EI scores. It might be that those users who do not take 
protective measures do not care about the consequences of ecstasy use and are as a 
consequence more susceptible to orbitofrontal damage and consequent negative affect 
and reduced EI.  However, this proposition is clearly speculative and further research 
is clearly called for. Indeed, users may be uncertain as to what are effective protective 
measures.  For example, monitoring fluid intake is less than straight forward since 
while keeping cool and drinking water reduces the risk of hyperthermia, excessive 
fluid intake may lead to hyponatraemia (Burgess et al, 2000; Gowing et al, 2002). 
Thus users need to be properly informed of the risks associated with taking ecstasy 
and how to minimise them. 
Switching the focus away from ecstasy/polydrug users to the sample as a 
whole, some interesting associations were observed between the EI measure and 
various other constructs. First high EI was associated with lower reported levels of 
anxiety, depression and arousal. These results are consistent with studies of individual 
differences among college students where low EI was associated with an increased an 
likelihood of depression and anxiety (Bastian et al, 2005; Fernández-Berrocal et al, 
2006; Wang 2002). We also found that higher levels of perceived parental control 
among our sample were associated with higher levels of EI. Again this is consistent 
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with Lopes et al’s (2003) study in which higher levels of parental support were 
associated with higher levels of EI. Interestingly in the present study perceived 
parental warmth was not associated with EI suggesting that it is the control aspect of 
parental support which may be associated with positive outcomes in terms of EI.  
The regression analyses revealed that the relationship between EI and 
respectively the psychological affect measures and parental control was robust and 
remained statistically significant following prior controls for the effects of age, 
gender, general intelligence and ecstasy use. Indeed these outcomes demonstrate that 
individual differences in EI are related to the quality of prior relationships with 
parents as might be expected and have predictable implications for psychological 
affect. Taken together with the non-significant correlations between EI and the other 
measures of intelligence the present results complement those which demonstrate that 
the EI measure captures potentially important aspects of individual variation which 
are distinct from those reflected in other measures of intelligence. While the findings 
reported here may further enhance the construct validity of the EI measure it is 
necessary to be cautious in this regard, since clearly we have only explored the pattern 
of inter-relationships within the current sample consisting as it does primarily of 
recreational drug users. 
Some limitations of the present study need to be acknowledged. First our 
participants were predominantly university students and therefore not wholly 
representative of the general population. Furthermore females were over-represented 
in the sample, constituting 60% thus future research would benefit from using a more 
balanced sample in terms of gender. Important aspects of our results rely on 
correlational and regression analyses. In the case of the perceptions of the effects of 
ecstasy use the sample size was less than might be considered desirable when wishing 
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to draw inferences concerning the importance of individual predictors (Tabachnick & 
Fidell, 2001). Furthermore, clearly these results cannot demonstrate causality. While 
lower levels of EI have been associated with raised levels of anxiety and depression in 
this and other studies, it does not follow that low EI causes mood impairments. It is 
also worthy of note that the parenting style measures were retrospective in nature and 
also subjective, rather than representing an objective assessment of parental practices. 
While this is a common limitation in research exploring the relationship between 
parenting practices and subsequent adult behaviour (egs. Emmelkamp & Heeres, 
1988; Schweitzer & Lawton, 1989) it cannot be ignored. An additional important 
limitation was that our drug use data was obtained entirely by self-report and was, 
therefore, subject to biases and limitations of memory. While, such self-report data is 
common to all such research dealing with substance misusers in the community it 
would have been desirable to have had toxicological samples so as to ensure that 
individuals were not intoxicated at the time of testing. Furthermore longer term 
patterns of use would have been more reliably assessed through the analysis of hair 
samples. Clearly future research would benefit from the inclusion of these measures. 
In conclusion, contrary to previous findings, the present study found that 
young adult ecstasy/polydrug users did not differ significantly in levels of EI 
compared to cannabis-only users and to nonusers of illicit drugs.  However, among 
ecstasy/polydrug users those who attributed adverse emotional reactions to ecstasy 
use had lower levels of EI. Equally those scoring lower on the EI measure were less 
likely to engage in protective behaviours while on drug. The possibility was raised 
that a particular sub-group of ecstasy users might be at increased risk of sustaining 
damage to the orbitofrontal cortex resulting in impaired emotional processing. Clearly 
further research is needed to explore this possibility.
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Table 1.  Parental Warmth and Control, Indicators of Psychological Affect, Intelligence, and the Use of Alcohol and Tobacco for Nonusers, 
Cannabis-Only Users and Ecstasy/Polydrug Users. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Nonusers Cannabis-Only Users Ecstasy/Polydrug Users Total 
 Mean S.D. n Mean S.D. n Mean S.D. n Mean S.D. n 
Age (years) 20.53 1.62 34 20.71 1.69 38 21.78 2.04 78 21.23 1.95 150 
Parental Warmth 12.05 2.31 31 12.05 2.25 37 11.06 2.91 76 11.53 2.66 144 
Parental Control 6.92 1.47 32 6.37 1.60 37 5.84 1.83 76 6.21 1.74 145 
Psychological Affect             
Arousal 20.15 2.99 34 18.92 4.47 38 19.70 3.67 76 19.60 3.76 148 
Anxiety 12.65 2.70 34 12.76 2.22 38 13.04 3.90 76 12.88 3.27 148 
Depression/Hedonic 
Tone 
12.68 2.32 34 12.74 2.62 38 13.50 3.26 76 13.11 2.91 148 
Intelligence             
Emotional 119.35 13.32 34 118.95 13.48 38 119.49 12.31 78 119.32 12.76 150 
Ravens 47.97 5.50 34 49.74 5.09 38 47.28 5.90 75 48.07 5.67 147 
NART 27.26 5.11 34 28.39 5.42 38 28.16 6.04 77 28.01 5.66 149 
             
Alcohol             
      Weeks since first use 300.50 111.20 32 339.09 128.46 35 403.53 123.19 76 364.70 128.70 143 
      Weeks since last use 1.52 4.87 32 0.37 0.39 35 0.44 0.88 77 0.66 2.41 144 
      Units per week 10.93 9.80 29 16.96 12.20 38 20.74 12.21 78 17.79 12.29 145 
Tobacco             
      Weeks since first use 230.80 128.76 5 327.25 150.66 24 412.19 165.74 54 376.70 166.65   83 
      Weeks since last use 16.83 18.60 5 9.84 31.31 25 11.03 48.76 54 11.02 42.67   84 
      Cigarettes per day 1.50 2.12 2 7.82 3.34 11 9.83 7.16 40 9.09 6.61   53 
 29 
 
Table 2 Indicators of Illicit Drug Use for the Two Drug Using Groups. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Cannabis-Only Users Polydrug Users Total 
 Mean S.D. n Mean S.D. n Mean S.D. n 
Average Dose (per week)          
Amphetamine (grams) . . 0 0.32 0.54 16 0.32 0.54 16 
Cannabis (joints) 2.33 3.29 23 7.63 10.46 57 6.10 9.30 80 
Cocaine (grams) . . 0 0.26 0.33 28 0.26 0.33 28 
Ecstasy (tablets) . . 0 1.71 1.73 78 1.71 1.73 78 
Lifetime Dose          
Amphetamine (grams) . . 0 61.64 108.44 19 61.64 108.44 19 
Cannabis (joints) 542.61 1056.12 23 2629.71 3898.14 60 2051.36 3480.78 83 
Cocaine (grams) . . 0 57.99 99.16 30 57.99 99.16 30 
Ecstasy (tablets) . . 0 316.49 476.74 78 316.49 476.74 78 
Weeks since first use          
Amphetamine . . 0 289.52 170.64 25 289.52 170.64 25 
Cannabis 207.58 140.55 38 326.88 142.78 64 282.43 152.69 102 
Cocaine . . 0 184.10 108.10 61 184.10 108.10 61 
Ecstasy . . 0 209.23 131.65 78 209.23 131.65 78 
Weeks since last use          
Amphetamine . . 0 124.60 135.59 25 124.60 135.59 25 
Cannabis 40.49 80.19 38 32.98 91.49 64 35.78 87.12 102 
Cocaine . . 0 16.36 43.91 60 16.36 43.91 60 
Ecstasy . . 0 29.71 61.21 78 29.71 61.21 78 
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Table 3  Correlation Coefficients Between Emotional Intelligence and Parental 
Warmth and Control, Psychological Affect and Intelligence Measures, and Self 
Perceptions of Ecstasy Use Scores. 
 
 
 Emotional 
Intelligence 
 Emotional 
Intelligence 
 
All Participants 
  
Ecstasy/Polydrug Users 
Only 
 
Parental Warmth   .084 Ecstasy has made  
participant more: 
 
Parental Control   .192* Caring   .071 
Psychological Affect  Paranoid - .330** 
Arousal   .294*** Alert - .037 
Anxiety - .243** Depressed - .351** 
Depression/Hedonic Tone - .310*** Sociable - .062 
Intelligence  Aggressive - .104 
Ravens   .107 Happy   .209 
NART   .035 Healthy   .200 
  Moody - .074 
  Patient   .255* 
  Irritable - .199 
  Confident   .046 
  Sad - .318* 
  Loving - .013 
  Confused - .104 
    
 
*** p<.001; ** p<.01; * p<.05 
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Table 4 
 
Outcomes for the Hierarchical Regressions of Perceptions of the Effects of Ecstasy 
Use, with Gender, Age, Intelligence Scores, Aspects of Ecstasy Use, and Emotional 
Intelligence as Predictors 
 
F value/R squared value 
      Predictor 
Dependent Variable 
 
  
 
Paranoid Depressed Patient Sad 
F (7,52) Full Model 2.74* 2.18
a
 2.11
 b
 2.38* 
R
2
 Full Model .269 .226 .222 .242 
Gender (β)c -.019 -.119 -.043 -.194 
Age (β) .154 -.009 .084 -.043 
Ravens (β) -.310* -.040 .340* .202 
NART (β) -.035 -.061 .298* -.239 
R
2
 Increment .160* .050 .156* .071 
Total ecstasy 
consumed (β) 
.203 .099 -.169 -.087 
Length of ecstasy 
use (β) 
-.094 .213 -.071 .280 
R
2
 Increment .034 .053 .038 .038 
Emotional 
intelligence (β) 
-.284* -.365** .171 -.378** 
R
2
 Increment .075* .124** .027 .133** 
 
a) p=.052 
b) p=.058 
c) in all cases, β refers to the standardised regression coefficient for the full model. 
 
** p<.01; * p<.05 
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Table 5  Emotional Intelligence Scores for Ecstasy Users According to Whether or Not they take Precautions, Rest Breaks, Monitor Fluid Intake 
and Restrict the Number of Tablets Taken When Taking Ecstasy. 
 
 
 No Yes F F with Ravens and 
NART scores as 
Covariates 
         
 Mean S.D. n Mean S.D. n  
 
 
         
Do you take any sort of 
precautions when using 
ecstasy?  
118.92 12.62 51 120.56 11.85 27 F<1 F<1 
When under the 
influence of ecstasy do 
you take rest breaks 
when dancing? 
112.81 13.36 21 122.05 11.10 56 F(1,75) = 9.46, p<.01 F(1,70) = 6.84, p<.05 
When under the 
influence of ecstasy do 
you monitor your fluid 
intake? 
113.74 12.61 19 121.43 11.80 58 F(1,75) = 5.88, p<.05 F(1,70) = 6.34, p<.05 
Is there a maximum 
number of ecstasy 
tablets  
you will take in one 
session? 
118.43 16.34 21 119.95 10.68 56 F<1 F<1 
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Table 6 
 
Outcomes for the Hierarchical Regressions of the Psychological Affect Measures and 
Parental Control, with Gender, Age, Intelligence Scores, Ecstasy Use, and Emotional 
Intelligence as Predictors 
 
 Dependent Variable 
 
 Anxiety Arousal Depression Parental 
Control 
F (6,148) Full Model 2.02
a
 2.67* 3.55** 4.08*** 
R
2
 Full Model .076 .098 .126 .144 
Gender (β) b -.013 -.122 -.072 .200** 
Age (β) -.052 .039 -.058 .012 
Ravens (β) -.108 -.074 -.057 -.075 
NART (β) -.023 -.009 .014 -.003 
R
2
 Increment .027 .013 .030 .089** 
Ecstasy 
User/Nonuser (β) 
-.045 .022 -.121 .168
 c
 
R
2
 Increment .001 .000 .010 .020
d
 
Emotional 
intelligence (β) 
-.220** .294*** -.296*** .186* 
R
2
 Increment .047** .085*** .086*** .034* 
 
 
a) p=.066 
b) in all cases β refers to the standardised regression coefficient for the full model. 
c) p=.050 
d) p=.069 
*** p<.001; ** p<.01; * p<.05 
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1
 Morgan (2000) indicates that the average recreational dose is between 0.75 and 4.00 mg/kg. 
